Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1261
-
1262
-
1263
-
1264
-
1265
-
1266
-
1267
-
1268
Contaminant levels (ng/g wt) in the sera of obese JCR rats treated with vehicle (V) or high dose (H) NCM with (E) or without (W) co-exposure to ethanol.
Published 2014Subjects: “…mitochondrial ATP synthase subunit ATP 5A…”
-
1269
-
1270
-
1271
-
1272
(R)-albuterol decreases cytokine levels in activated murine splenocytes
Published 2011“…</p><p></p> (R)-albuterol (R), (S)-albuterol (S) or racemic albuterol (R + S) at a dose (10M) were added to murine splenocytes pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP), (Fig 3 A, B). …”
-
1273
p35 siRNA knockdown decreased Cdk5 activity, diminished WT1 expression and viable cell numbers, but did not affect a cell apoptosis marker as detected by WB.
Published 2016“…A&B. Western blots show that p35 siRNA-transfected podocytes successfully decrease p35 expression (upper panel, lane 2) compared to the control siRNA cells (p<0.05), but did not affect cyclin I expression (3<sup>rd</sup> panel). …”
-
1274
-
1275
-
1276
-
1277
-
1278
Decreased dermal and corneal stromal collagen in <i>Slc39a13</i>-KO mice.
Published 2008“…Collagen of corneal stroma is decreased in <i>Slc39a13</i>-KO mice. H&E (left) and Azan (middle) staining show 5-week-old <i>Slc39a13</i>-KO cornea is thinner than wild-type littermates. …”
-
1279
-
1280
Blocking TNF or IL-6 decreases HIV-1 replication significantly in a dose dependent manner.
Published 2013“…Blocking TNF (at 2 ug/ml or 5 ug/ml) or IL-6 (5 ug/ml) significantly decreased virus replication (*, p<0.05) as compared to the same concentrations of an IgG<sub>1</sub> control antibody. …”